Frontier Bio
Frontier Bio creates lab-grown human tissues to eliminate the organ transplant list and as an ethical alternative to animal studies. They're starting with blood vessels since they are the foundation for all tissues.
Frontier Bio
Frontier Bio is currently seeking investment
Frontier Bio is seeking a seed investment in the range of less-than-1m
What We Do
Frontier Bio develops complex microscale lung tissue using 3D bioprinting and stem cells, aimed at transforming therapies for respiratory diseases and organ transplantation.
Frontier Bio creates neural microtissues that replicate the brain's complex vasculature and Blood-Brain Barrier for drug discovery and disease modeling.
Frontier Bio develops lab-grown tissue-engineered blood vessels as an alternative platform for testing vascular medical devices, reducing the use of animal models.
Frontier Bio offers custom project development in tissue engineering, tailored to specific research and application needs.
Frontier Bio offers high-impact, reproducible science services centered around client questions and needs, creating research plans for specific inquiries.
Frontier Bio provides unique internship opportunities in Mechatronics Engineering, Biology/Bioengineering/Biomedical Engineering, and Business Development, focusing on high-impact projects and product development.
Application Area
Show More (1)Diagnostics
Digital Health Technologies
Show More (5)Drugs
Services
Key People
News & Updates
Frontier Bio was nominated for the 3D Printing Industry Awards 2024, recognizing its leadership in additive manufacturing and innovation in 3D bioprinting.
Frontier Bio announced a groundbreaking achievement in lab-grown lung tissue, paving the way for advancements in treating respiratory diseases and organ transplantation.
Frontier Bio unveiled a transformative method to fabricate living human blood vessels, aiming to replace animal testing in medical device testing.